ABCB1 and lung adenocarcinoma: Gao et al. have determined the ABCB1 promoter methylation status in tumor samples from 36 patients with bronchioloalveolar carcinoma, a subtype of lung adenocarcinoma, and ten normal lung tissue samples from patients with inflammatory pseudotumors [150].